BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.175
0.00 (0.00%)
Sep 11, 2026, 3:32 PM CET
BioPorto Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 74.44 | 54.89 | 59.66 | 66.4 | 81.79 | 45.52 |
Cash & Short-Term Investments | 74.44 | 54.89 | 59.66 | 66.4 | 81.79 | 45.52 |
Cash Growth | 55.85% | -8.00% | -10.15% | -18.82% | 79.67% | -57.83% |
Accounts Receivable | 8.67 | 10.56 | 9.39 | 3.31 | 2.83 | 7.18 |
Other Receivables | 7.23 | 7.96 | 7.76 | 7.05 | 8.21 | 7.01 |
Receivables | 15.9 | 18.52 | 17.15 | 10.35 | 11.04 | 14.19 |
Inventory | 5 | 9.25 | 4.64 | 3.79 | 2.56 | 2.72 |
Prepaid Expenses | 2.94 | 2.29 | 2.45 | 1.74 | 1.56 | 1.77 |
Other Current Assets | - | - | - | - | 4.48 | - |
Total Current Assets | 99.43 | 84.96 | 83.9 | 82.28 | 101.43 | 64.2 |
Property, Plant & Equipment | 5.25 | 6.35 | 8.72 | 2.17 | 4.51 | 14.27 |
Other Intangible Assets | 0.07 | 0.14 | 0.28 | 0.46 | 0.77 | 1.05 |
Long-Term Accounts Receivable | - | 0.39 | 1.71 | 2.73 | - | - |
Other Long-Term Assets | 4.53 | 1.35 | 1.39 | 2.17 | 1.93 | 1.74 |
Total Assets | 109.27 | 93.18 | 95.98 | 89.81 | 108.64 | 81.26 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.83 | 14.02 | 11.33 | 6.91 | 10.46 | 4.26 |
Accrued Expenses | 11.18 | 8.63 | 5.72 | 15.42 | 17.24 | 17.47 |
Current Portion of Leases | 3.31 | 3.47 | 3.34 | 2.97 | 3.2 | 2.83 |
Current Income Taxes Payable | - | - | - | 0.08 | 0.08 | 0.08 |
Other Current Liabilities | - | - | - | - | - | 0.14 |
Total Current Liabilities | 24.32 | 26.12 | 20.39 | 25.37 | 30.97 | 24.79 |
Long-Term Leases | 2.53 | 4.05 | 7.85 | 4.28 | 7.45 | 10.2 |
Other Long-Term Liabilities | - | - | - | - | - | 0.3 |
Total Liabilities | 26.84 | 30.17 | 28.23 | 29.65 | 38.42 | 35.29 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 495.11 | 495.11 | 429.67 | 379.67 | 334.69 | 267.75 |
Retained Earnings | -413.33 | -433.32 | -360.87 | -319.74 | -264.24 | -221.67 |
Comprehensive Income & Other | 0.65 | 1.22 | -1.05 | 0.23 | -0.23 | -0.12 |
Shareholders' Equity | 82.43 | 63.01 | 67.75 | 60.16 | 70.22 | 45.96 |
Total Liabilities & Equity | 109.27 | 93.18 | 95.98 | 89.81 | 108.64 | 81.26 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5.83 | 7.52 | 11.19 | 7.25 | 10.65 | 13.03 |
Net Cash (Debt) | 68.61 | 47.37 | 48.47 | 59.15 | 71.15 | 32.49 |
Net Cash Growth | 77.63% | -2.27% | -18.05% | -16.86% | 118.99% | -66.60% |
Net Cash Per Share | 0.12 | 0.09 | 0.12 | 0.17 | 0.22 | 0.12 |
Filing Date Shares Outstanding | 495.11 | 495.11 | 429.66 | 379.66 | 334.68 | 267.74 |
Total Common Shares Outstanding | 495.11 | 495.11 | 429.66 | 379.66 | 334.68 | 267.74 |
Working Capital | 75.12 | 58.83 | 63.51 | 56.91 | 70.46 | 39.41 |
Book Value Per Share | 0.17 | 0.13 | 0.16 | 0.16 | 0.21 | 0.17 |
Tangible Book Value | 82.36 | 62.87 | 67.47 | 59.7 | 69.46 | 44.92 |
Tangible Book Value Per Share | 0.17 | 0.13 | 0.16 | 0.16 | 0.21 | 0.17 |
Machinery | - | 7.76 | 7.86 | 6.09 | 6.08 | 5.62 |